GENE ONLINE|News &
Opinion
Blog

RSV vaccines
GeneOnline’s Pick: Top 10 Global Industry News Stories in 2023 (Part 1)
2024-01-08
GeneOnline’s Pick: Top 10 Global Biotech News Stories in 2023
2023-12-27
GeneOnline’s Weekly News Highlights: Oct 22-Oct 27
2023-10-31
Sanofi and AstraZeneca’s RSV Antibody Drug Gets FDA Approval, Adding New Weapon for Preventing Infant Infections
2023-07-18
Recent Highlights of the RSV Vaccine Battle, with More Regulatory Approvals in Sight
2023-06-08
GSK Wins Approval For World’s First RSV Vaccine
2023-05-08
Pfizer and GSK Neck and Neck for First FDA-Approved RSV Vaccine
2023-03-03
Pfizer’s RSV Vaccine Wins Support From FDA Advisory Panel for Use in Older Adults
2023-03-01
Moderna Welcomes Phase 3 Win For RSV Vaccine
2023-01-18
GeneOnline’s Pick: Top 10 Industry News Stories in 2022
2022-12-26
CDC Warns Of “Tripledemic” Winter Amid Rising Flu And RSV Cases
2022-11-14
The First Approved RSV Vaccine Worldwide Belongs to AstraZeneca and Sanofi
2022-11-06
GSK’s RSV Vaccine Candidate Has Won Another Regulatory Review
2022-11-03
GSK Posts Stellar Results from Phase 3 RSV Vaccine Trial
2022-10-13
AstraZeneca, Sanofi’s RSV Antibody Recommended For Approval In EU
2022-09-19
1 2
LATEST
Eli Lilly Breaks Records with $9B Total Investment in Indiana Weight-loss Drug Expansion
2024-05-27
New Regulatory Measures in China A First in the Fight Against Sedentary Behavior in Children
2024-05-24
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at ASGCT 2024
2024-05-23
AstraZeneca’s $1.5 Billion ADC Manufacturing Facility in Singapore
2024-05-23
Hims & Hers Health Inc. Tipping the Scales of the Weight Loss Market — and Wall Street is Loving it!
2024-05-22
GV Announces Cooperation with CICC
2024-05-22
Eli Lilly and Aktis Oncology Partner to Advance Novel Radiopharmaceuticals
2024-05-22
EVENT
Scroll to Top